Friday 6 November 2026 Export GKOS’s income statement to Excel — free account

Glaukos Corporation

GKOS Healthcare Medical Devices

Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024.

Revenue: +58.0%
EPS: +110.7%
Free cash flow: +411.2%
Total debt: −2.25%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

224.21 4.23 +1.92%

Follow GKOS

Alert me

Market cap: $13.0B
P/E: 0.0×
Fwd P/E: −803×
Dividend yield: —
F-score: 3/9
Altman Z: 15.20
Beneish M: −2.96
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Glaukos Corporation 10-Q filed Aug 4, 2025

Fiscal Q2 2025 · Period ended Jun 30, 2025 · Filed Aug 4, 2025 · accepted 4:56 PM ET · Document on sec.gov · Filing index

Nothing in this filing raised a red flag. The document itself is on sec.gov.

Read the filing on sec.gov